Hlf is a genetic modifier of epilepsy caused by voltage-gated sodium channel mutations

Nicole Alise Hawkins, Jennifer A Kearney*

*Corresponding author for this work

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Mutations in voltage-gated sodium channel genes cause several types of human epilepsies. Often, individuals with the same sodium channel mutation exhibit diverse phenotypes. This suggests that factors beyond the primary mutation influence disease severity, including genetic modifiers. Mouse epilepsy models with voltage-gated sodium channel mutations exhibit strain-dependent phenotype variability, supporting a contribution of genetic modifiers in epilepsy. The Scn2aQ54 (Q54) mouse model has a strain-dependent epilepsy phenotype. Q54 mice on the C57BL/6J (B6) strain exhibit delayed seizure onset and improved survival compared to [B6xSJL/J]F1.Q54 mice. We previously mapped two dominant modifier loci that influence Q54 seizure susceptibility and identified Hlf (hepatic leukemia factor) as a candidate modifier gene at one locus. Hlf and other PAR bZIP transcription factors had previously been associated with spontaneous seizures in mice thought to be caused by down-regulation of the pyridoxine pathway. An Hlf targeted knockout mouse model was used to evaluate the effect of Hlf deletion on Q54 phenotype severity. HlfKO/KO;Q54 double mutant mice exhibited elevated frequency and reduced survival compared to Q54 controls. To determine if direct modulation of the pyridoxine pathway could alter the Q54 phenotype, mice were maintained on a pyridoxine-deficient diet for 6 weeks. Dietary pyridoxine deficiency resulted in elevated seizure frequency and decreased survival in Q54 mice compared to control diet. To determine if Hlf could modify other epilepsies, HlfKO/+ mice were crossed with the Scn1aKO/+ Dravet syndrome mouse model to examine the effect on premature lethality. HlfKO/+;Scn1aKO/+ offspring exhibited decreased survival compared to Scn1aKO/+ controls. Together these results demonstrate that Hlf is a genetic modifier of epilepsy caused by voltage-gated sodium channel mutations and that modulation of the pyridoxine pathway can also influence phenotype severity.

Original languageEnglish (US)
Pages (from-to)20-23
Number of pages4
JournalEpilepsy Research
Volume119
DOIs
StatePublished - Jan 1 2016

Fingerprint

Voltage-Gated Sodium Channels
Epilepsy
Leukemia
Mutation
Liver
Pyridoxine
Phenotype
Seizures
Survival
Vitamin B 6 Deficiency
Basic-Leucine Zipper Transcription Factors
Modifier Genes
Myoclonic Epilepsy
Diet
Sodium Channels
Inbred C57BL Mouse
Knockout Mice
Down-Regulation

Keywords

  • Epilepsy
  • Genetics
  • Mouse model
  • Seizure
  • Voltage-gated sodium channel

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

@article{c58d09ed15d04411bb4c0e5b195dd60e,
title = "Hlf is a genetic modifier of epilepsy caused by voltage-gated sodium channel mutations",
abstract = "Mutations in voltage-gated sodium channel genes cause several types of human epilepsies. Often, individuals with the same sodium channel mutation exhibit diverse phenotypes. This suggests that factors beyond the primary mutation influence disease severity, including genetic modifiers. Mouse epilepsy models with voltage-gated sodium channel mutations exhibit strain-dependent phenotype variability, supporting a contribution of genetic modifiers in epilepsy. The Scn2aQ54 (Q54) mouse model has a strain-dependent epilepsy phenotype. Q54 mice on the C57BL/6J (B6) strain exhibit delayed seizure onset and improved survival compared to [B6xSJL/J]F1.Q54 mice. We previously mapped two dominant modifier loci that influence Q54 seizure susceptibility and identified Hlf (hepatic leukemia factor) as a candidate modifier gene at one locus. Hlf and other PAR bZIP transcription factors had previously been associated with spontaneous seizures in mice thought to be caused by down-regulation of the pyridoxine pathway. An Hlf targeted knockout mouse model was used to evaluate the effect of Hlf deletion on Q54 phenotype severity. HlfKO/KO;Q54 double mutant mice exhibited elevated frequency and reduced survival compared to Q54 controls. To determine if direct modulation of the pyridoxine pathway could alter the Q54 phenotype, mice were maintained on a pyridoxine-deficient diet for 6 weeks. Dietary pyridoxine deficiency resulted in elevated seizure frequency and decreased survival in Q54 mice compared to control diet. To determine if Hlf could modify other epilepsies, HlfKO/+ mice were crossed with the Scn1aKO/+ Dravet syndrome mouse model to examine the effect on premature lethality. HlfKO/+;Scn1aKO/+ offspring exhibited decreased survival compared to Scn1aKO/+ controls. Together these results demonstrate that Hlf is a genetic modifier of epilepsy caused by voltage-gated sodium channel mutations and that modulation of the pyridoxine pathway can also influence phenotype severity.",
keywords = "Epilepsy, Genetics, Mouse model, Seizure, Voltage-gated sodium channel",
author = "Hawkins, {Nicole Alise} and Kearney, {Jennifer A}",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.eplepsyres.2015.11.016",
language = "English (US)",
volume = "119",
pages = "20--23",
journal = "Epilepsy Research",
issn = "0920-1211",
publisher = "Elsevier",

}

TY - JOUR

T1 - Hlf is a genetic modifier of epilepsy caused by voltage-gated sodium channel mutations

AU - Hawkins, Nicole Alise

AU - Kearney, Jennifer A

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Mutations in voltage-gated sodium channel genes cause several types of human epilepsies. Often, individuals with the same sodium channel mutation exhibit diverse phenotypes. This suggests that factors beyond the primary mutation influence disease severity, including genetic modifiers. Mouse epilepsy models with voltage-gated sodium channel mutations exhibit strain-dependent phenotype variability, supporting a contribution of genetic modifiers in epilepsy. The Scn2aQ54 (Q54) mouse model has a strain-dependent epilepsy phenotype. Q54 mice on the C57BL/6J (B6) strain exhibit delayed seizure onset and improved survival compared to [B6xSJL/J]F1.Q54 mice. We previously mapped two dominant modifier loci that influence Q54 seizure susceptibility and identified Hlf (hepatic leukemia factor) as a candidate modifier gene at one locus. Hlf and other PAR bZIP transcription factors had previously been associated with spontaneous seizures in mice thought to be caused by down-regulation of the pyridoxine pathway. An Hlf targeted knockout mouse model was used to evaluate the effect of Hlf deletion on Q54 phenotype severity. HlfKO/KO;Q54 double mutant mice exhibited elevated frequency and reduced survival compared to Q54 controls. To determine if direct modulation of the pyridoxine pathway could alter the Q54 phenotype, mice were maintained on a pyridoxine-deficient diet for 6 weeks. Dietary pyridoxine deficiency resulted in elevated seizure frequency and decreased survival in Q54 mice compared to control diet. To determine if Hlf could modify other epilepsies, HlfKO/+ mice were crossed with the Scn1aKO/+ Dravet syndrome mouse model to examine the effect on premature lethality. HlfKO/+;Scn1aKO/+ offspring exhibited decreased survival compared to Scn1aKO/+ controls. Together these results demonstrate that Hlf is a genetic modifier of epilepsy caused by voltage-gated sodium channel mutations and that modulation of the pyridoxine pathway can also influence phenotype severity.

AB - Mutations in voltage-gated sodium channel genes cause several types of human epilepsies. Often, individuals with the same sodium channel mutation exhibit diverse phenotypes. This suggests that factors beyond the primary mutation influence disease severity, including genetic modifiers. Mouse epilepsy models with voltage-gated sodium channel mutations exhibit strain-dependent phenotype variability, supporting a contribution of genetic modifiers in epilepsy. The Scn2aQ54 (Q54) mouse model has a strain-dependent epilepsy phenotype. Q54 mice on the C57BL/6J (B6) strain exhibit delayed seizure onset and improved survival compared to [B6xSJL/J]F1.Q54 mice. We previously mapped two dominant modifier loci that influence Q54 seizure susceptibility and identified Hlf (hepatic leukemia factor) as a candidate modifier gene at one locus. Hlf and other PAR bZIP transcription factors had previously been associated with spontaneous seizures in mice thought to be caused by down-regulation of the pyridoxine pathway. An Hlf targeted knockout mouse model was used to evaluate the effect of Hlf deletion on Q54 phenotype severity. HlfKO/KO;Q54 double mutant mice exhibited elevated frequency and reduced survival compared to Q54 controls. To determine if direct modulation of the pyridoxine pathway could alter the Q54 phenotype, mice were maintained on a pyridoxine-deficient diet for 6 weeks. Dietary pyridoxine deficiency resulted in elevated seizure frequency and decreased survival in Q54 mice compared to control diet. To determine if Hlf could modify other epilepsies, HlfKO/+ mice were crossed with the Scn1aKO/+ Dravet syndrome mouse model to examine the effect on premature lethality. HlfKO/+;Scn1aKO/+ offspring exhibited decreased survival compared to Scn1aKO/+ controls. Together these results demonstrate that Hlf is a genetic modifier of epilepsy caused by voltage-gated sodium channel mutations and that modulation of the pyridoxine pathway can also influence phenotype severity.

KW - Epilepsy

KW - Genetics

KW - Mouse model

KW - Seizure

KW - Voltage-gated sodium channel

UR - http://www.scopus.com/inward/record.url?scp=84955242276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955242276&partnerID=8YFLogxK

U2 - 10.1016/j.eplepsyres.2015.11.016

DO - 10.1016/j.eplepsyres.2015.11.016

M3 - Article

C2 - 26656780

AN - SCOPUS:84955242276

VL - 119

SP - 20

EP - 23

JO - Epilepsy Research

JF - Epilepsy Research

SN - 0920-1211

ER -